SCHEMBL14153147

SCHEMBL14153147

COC(COn1nnc2ccccc21)C(=O)O

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.53
RAB9A P51151 3/20 0.53
SMN1; SMN2 Q16637 2/20 0.53
TSHR P16473 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
RXFP1 Q9HBX9 1/20 0.50
POLB P06746 2/20 0.48
APAF1 O14727 1/20 0.48
HDAC3 O15379 3/20 0.47
HDAC4 P56524 3/20 0.47
HDAC1 Q13547 3/20 0.47
HDAC7 Q8WUI4 3/20 0.47
HDAC2 Q92769 3/20 0.47
HDAC10 Q969S8 3/20 0.47
HDAC11 Q96DB2 3/20 0.47
HDAC8 Q9BY41 3/20 0.47
HDAC6 Q9UBN7 3/20 0.47
HDAC9 Q9UKV0 3/20 0.47
HDAC5 Q9UQL6 3/20 0.47
ALDH1A1 P00352 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19586998 0.76 RAB9A (0.60) NPC1RAB9ASMN1; SMN2TSHRNPSR1
SCHEMBL17103166 0.75 TSHR (0.58) NPC1RAB9ASMN1; SMN2TSHRNPSR1
SCHEMBL11018138 0.73 SMN1; SMN2 (0.59) NPC1RAB9ASMN1; SMN2TSHRNPSR1
SCHEMBL4757056 0.73 HDAC3 (0.62) NPC1RAB9ASMN1; SMN2TSHRNPSR1
SCHEMBL6697985 0.72 TSHR (0.55) NPC1RAB9ASMN1; SMN2TSHRNPSR1
SCHEMBL17103078 0.72 TSHR (0.67) NPC1RAB9ASMN1; SMN2TSHRNPSR1
SCHEMBL4006352 0.72 TSHR (0.67) NPC1RAB9ASMN1; SMN2TSHRNPSR1
SCHEMBL5497702 0.72 RAB9A (0.46) NPC1RAB9ASMN1; SMN2TSHRNPSR1
SCHEMBL11269065 0.72 TSHR (0.58) NPC1RAB9ASMN1; SMN2TSHRNPSR1
SCHEMBL5849741 0.71 EGLN3 (0.55) NPC1RAB9ASMN1; SMN2TSHRNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012162635-A1 METABOTROPIC GLUTAMATE RECEPTORS 5 MODULATORS AND METHODS OF USE THEREOF SUNOVION PHARMACEUTICALS INC. (US) 2012-11-29 WO disclosed